Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Lexagene Holdings Inc (LXG) NPV

Sell:0.74 CAD Buy:0.75 CAD Change: 0.02 CAD (2.74%)
Market closed |  Prices as at close on 23 October 2020 | Switch to live prices |
Sell:0.74 CAD
Buy:0.75 CAD
Change: 0.02 CAD (2.74%)
Market closed |  Prices as at close on 23 October 2020 | Switch to live prices |
Sell:0.74 CAD
Buy:0.75 CAD
Change: 0.02 CAD (2.74%)
Market closed |  Prices as at close on 23 October 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

LexaGene Holdings, Inc. is a Canada-based molecular diagnostics company. The Company develops genetic analyzers for pathogen detection and other molecular markers for on-site testing in veterinary diagnostics, food safety and for use in open-access markets, including clinical research, agricultural testing and biodefense. It offers MiQLab genetic analyzer. The MiQLab genetic analyzer offers automated pathogen detection and customized testing. The MiQLab genetic analyzer draws each liquid sample into a sample preparation cartridge, where microbes are concentrated and lysed before the genetic material is purified. Its analyzer pulls the purified genomic material from inside the cartridge into the system’s microfluidics where a series of real-time polymerase chain reaction (PCR) mixtures are assembled, multiplex quantitative polymerase chain reactions (qPCR) are amplified and the results are analyzed.

Contact details

500 Cummings Ctr Ste 4550
United States
+1 (604) 6810084

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
83.41 million CAD
Shares in issue:
114.08 million
Health Care Equipment
Canadian Venture Exchange
Canadian dollars

Key personnel

  • John Regan
    Chairman of the Board, Chief Executive Officer
  • Daryl Rebeck
    President, Director
  • Jeffrey Mitchell
    Chief Financial Officer
  • Greg Dale
    Vice President - Product Development and Manufacturing
  • Allan Fabbro
    Vice President - Corporate Development
  • Steven Armstrong
    Senior Director - Operations

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.